콘텐츠로 건너뛰기
Merck
  • Mechanistic studies of the inactivation of tyrosinase by resorcinol.

Mechanistic studies of the inactivation of tyrosinase by resorcinol.

Bioorganic & medicinal chemistry (2013-01-29)
Michael R L Stratford, Christopher A Ramsden, Patrick A Riley
초록

The inactivation of tyrosinase by resorcinol (1,3-dihydroxybenzene) and seventeen simple derivatives has been investigated using combined spectrophotometry and oximetry together with hplc/ms examination of the oxidation products. The results are consistent with a Quintox mechanism, analogous to that proposed for catechol inactivation of tyrosinase, in which the resorcinol substrate is oxidised via the monooxygenase route leading to a hydroxy intermediate that undergoes deprotonation and results in irreversible elimination of Cu(0) from the active site. Hplc/ms evidence for formation of the resorcinol monooxygenase product (3-hydroxy-ortho-quinone) is presented and the relationship between the ring position of simple resorcinol substituents (H, Me, F, Cl) and tyrosinase inactivation is rationalised.

MATERIALS
제품 번호
브랜드
제품 설명

Supelco
Resorcinol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Pyrocatechol, ≥99%
Sigma-Aldrich
Resorcinol, BioXtra, ≥99%
Sigma-Aldrich
Resorcinol, ACS reagent, ≥99.0%
Sigma-Aldrich
Resorcinol, ReagentPlus®, 99%
Sigma-Aldrich
Pyrocatechol, purified by sublimation, ≥99.5%
Sigma-Aldrich
Resorcinol, meets analytical specification of Ph. Eur., BP, 98.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
Resorcinol, ≥98%, FG
Sigma-Aldrich
1,2-Dihydroxybenzene, ReagentPlus®, ≥99%